The fluorescent protein toolbox has revolutionized experimental biology. Despite this advance, no fluorescent proteins have been identified from vertebrates, nor has chromogenic ligand-inducible activation or clinical utility been demonstrated. Here, we report the cloning and characterization of UnaG, a fluorescent protein from Japanese eel. UnaG belongs to the fatty-acid-binding protein (FABP) family, and expression in eel is restricted to small-diameter muscle fibers. On heterologous expression in cell lines or mouse brain, UnaG produces oxygen-independent green fluorescence. Remarkably, UnaG fluorescence is triggered by an endogenous ligand, bilirubin, a membrane-permeable heme metabolite and clinical health biomarker. The holoUnaG structure at 1.2 Å revealed a biplanar coordination of bilirubin by reversible p-conjugation, and we used this high-affinity and high-specificity interaction to establish a fluorescence-based human bilirubin assay with promising clinical utility. UnaG will be the prototype for a versatile class of ligandactivated fluorescent proteins, with applications in research, medicine, and bioengineering.
INTRODUCTION
The discovery of fluorescent proteins has been instrumental for the advancement of biomedical research. In addition to Aequorea GFPs (Tsien, 1998) and GFP-like proteins (Chudakov et al., 2010; Miyawaki et al., 2012) , near-infrared (NIR) fluorescent proteins developed from bacterial phytochromes have expanded the range of experimental tools (Piatkevich et al., 2013) . Though protein engineering continues to refine the current panel of biosensors, nature continues to remain the most reliable source of novel fluorescent proteins. In recent years, we have attempted to identify fluorescent proteins with unique biological properties lacking in known sensors. In particular, fluorescent proteins from vertebrates are unknown to date, but their identification could provide research tools with considerable advantages in biological stability and utility for experimental and medical applications compared to existing proteins from lower organisms. Similarly, all known fluorescent proteins have either constitutive fluorescence or covalent-bound ligands, and there are no known proteins with diffusible chromogenic ligands and ligand-inducible properties that could facilitate the development of important new classes of chemical-genetic fluorescent switches. Finally, no fluorescent proteins at present are known to have direct practical clinical application in human health, despite their extensive utility in biomedical research.
Unagi, the Japanese freshwater eel (Anguilla japonica), is a historical dietary staple of Japanese cuisine. In their life cycle, the eels travel thousands of kilometers into the open ocean to spawn in the Philippine Sea, and the larvae make a return journey to freshwater habitats over several months (Tsukamoto, 2006) . This long-distance migration cycle is believed to impose considerable demands on eel musculoskeletal physiology, particularly for the maintenance of steady-state muscle homeostasis and anaerobic oxidative metabolism during continuous swimming. But there has been very little research on the mechanisms of muscle metabolic physiology during travel in eels and other long-distance migratory animals. A potential clue emerged in 2009, when it was reported that muscle fibers from unagi are fluorescent, and fragmental amino acid sequences suggested that the fluorescence derived from a low molecular mass protein (Hayashi and Toda, 2009 ). This preliminary observation pointed to an unexpected entry point for understanding the mechanism of eel muscle physiology if the molecular basis of its muscle fluorescence could be understood via identification of the protein.
In this study, we report the complete characterization of the putative unagi fluorescent protein. We cloned a full-length cDNA and showed that the corresponding polypeptide belongs to the fatty-acid-binding protein (FABP) family (Storch and Thumser, 2000; Schaap et al., 2002; Zimmerman and Veerkamp, 2002) , a class of proteins with known or suspected roles in oxidative metabolism. Expression of the protein we name UnaG indicates that it does not have intrinsic fluorescence, so we conducted an extensive search for the putative ligand. Surprisingly, we discovered that the protein becomes fluorescent via noncovalent, highaffinity, high-specificity binding to unconjugated bilirubin, the major heme metabolite in animal physiology, a common marker for liver function in hospital laboratories and a key indicator for the prevalent childhood diseases of jaundice and kernicterus. We determined the structure of holoUnaG at 1.2 Å and identified the bilirubin-binding site as a biplanar p-conjugated structure that may be useful for designing inducible fluorescent protein switches. This unique binding fold allowed us to develop a simple, sensitive, fluorometric method for quantifying bilirubin from human clinical samples, an assay that is superior to current tests, and therefore may have global health care application. Together, these studies reveal a new class of ligand-inducible fluorescent proteins with both experimental and clinical importance and a starting point for understanding muscle oxidative mechanisms, particularly in migratory species with continuous metabolic demands.
RESULTS

Molecular Cloning of an Atypical Green Fluorescent Protein from Eel Muscle
We searched for eel samples enriched with green fluorescence and found that juvenile (glass) eels of Anguilla japonica were strongly fluorescent (Movie S1 available online). Complementary DNAs (cDNAs) were synthesized from five glass eels. To obtain a full-length clone and to establish the identity of the putative green fluorescent protein from eel muscle, degenerate primers were used, representing variations in nine partial peptides whose amino acid sequences had been determined (Hayashi and Toda, 2009) . A cDNA clone encoding a full-length protein composed of 139 amino acids was identified (clone #21). The protein belongs to the fatty-acid-binding protein (FABP) family (Storch and Thumser, 2000; Schaap et al., 2002; Zimmerman and Veerkamp, 2002) with the highest homology (56%) to brain (B-) FABP ( Figure 1A ). Expression of His-tagged clone #21 in bacterial cultures did not produce fluorescence (Figures S1A and S1B) , but transfection of FLAG-tagged clone #21 into cultured mammalian (HeLa) cells produced bright green fluorescence comparable to that of enhanced GFP (EGFP) (Figure 1B) . Robust green fluorescence of clone #21 was also observed with intensities comparable to the red fluorescence of a fusion partner (mCherry) in embryonic mouse brain 24 hr after in utero electroporation on embryonic day 15.5 ( Figure 1C ). Together, these results establish clone #21 as the fluorescent protein from eel muscle and show its utility as a fluorescent marker in living cells and in animals. We named the protein UnaG, being from Unagi eel and emitting green fluorescence. To establish experimental utility, the tolerance of N-and C-terminal polypeptide fusions to UnaG was confirmed by observing undiminished green and red fluorescence from mCherry-UnaG and UnaGmCherry each expressed in cultured HeLa cells ( Figure S1C ).
To further examine the fluorescence mechanism, posttransfection cells were exposed to hypoxic conditions (0.1% oxygen) for 12 hr. After transfection with pcDNA3/FLAG-#21, cells developed strong green fluorescence 4 hr after transfection, and subsequent reoxygenation at 20 hr did not affect fluorescence ( Figure 1D , top). In contrast, cells transfected with control pcDNA3/EGFP had faint fluorescence after a 20 hr hypoxia treatment, which increased during a 2 hr reoxygenation period ( Figure 1D , bottom). Such oxygen independence of UnaG fluorescence was highlighted with a fusion partner (mCherry), which could function as an internal reference during hypoxia experiments ( Figure 1E ). Therefore, unlike GFP, the green fluorescence of UnaG is not limited to aerobic conditions, suggesting that UnaG should have expansive utility in many important cell and animal systems in which anaerobic conditions prevail and GFP signals are not capable of being produced.
Identification of Bilirubin as the UnaG Fluorogenic Chromophore
Given that it does not fluoresce in bacteria, we hypothesized that UnaG required an unidentified mammalian cofactor(s) to fluoresce. As a member of the FABP family, we first assumed that UnaG could form a reversible complex with a fatty acid or related analog as its chromophore. To identify the UnaG ligand molecule, we took two approaches that employed a recombinant protein. First, FLAG-tagged UnaG expressed in HEK293 cells was used as the holoprotein for a single-step biochemical purification, where fluorescent holoUnaG was treated with chloroform/methanol for extraction of the noncovalently bound ligand(s). We analyzed extracts in the organic phase by mass spectrometry and identified a substance with a molecular mass of 585.30 Da and absorption at 450 nm that was unstable, presumably due to oxidation. Second, recombinant UnaG was used as an apoprotein; GST-apoUnaG was purified from bacterial lysates, and after removal of the GST moiety, apoUnaG was mixed with a large number of biological materials in search for those that could induce fluorescence. The serum from most Table S1 . (C) Normalized excitation (broken line) and emission (solid line) of holoUnaG (green) and bilirubin (BR) (yellow). See also Table S1 .
animals was capable of rendering the apoprotein fluorescent ( Figure S2A ). Fetal bovine serum (FBS) was the most effective among the tested sera. We fractionated FBS proteins by ultracentrifugation and identified fluorescence in fractions containing albumin and high-density lipoprotein (HDL) ( Figure S2B ). Similar results were obtained by using human serum ( Figure S2C ). Given these results, we predicted bilirubin (BR) to be the ligand. Indeed, addition of BR to the apoprotein resulted in immediate fluorescence ( Figure 2A and Movie S2). HoloUnaG absorbed light maximally at 498 nm (ε 498 = 77,300 M À1 3 cm À1 ) ( Figure 2B ); the binding red shifted the absorption of BR by 48 nm. When excited with blue light, holoUnaG emitted a bright green fluorescence at 527 nm ( Figure 2C ). The absolute fluorescence quantum yield was determined to be 0.51 and stable at pH 4-11. The intrinsic fluorescence of holoUnaG is greater than that of EGFP (Table  S1 ), suggesting that it is a stronger backbone for further genetic optimization in the green spectral range. Together, these results indicate that bilirubin is a fluorescent chromophore with unique properties compared with known sensors.
Atomic Structure of HoloUnaG at 1.2 Å Reveals a Ligand Interface To study the mechanism of UnaG binding to the BR fluorogenic chromophore, we solved the crystallographic structure of the holoUnaG complex at 1.2 Å resolution (Table S2) . Like other members of the FABP family, the structure consists of 10 antiparallel b strands forming a b barrel that is capped by two short a helices. Bound BR is inserted within the barrel in a central internal cavity ( Figure 3A) . A high-resolution electron density map clearly identifies the C5-Z C15-Z configuration ( Figure 3B ). The exo-vinyl dipyrrinone moiety (rings C/D) and the B-ring propionate are accommodated deep in the cavity, whereas the endo-vinyl dipyrrinone moiety (rings A/B) and the C-ring propionate are positioned near the entrance. The planar conformation is evident when viewed from particular angles ( Figure 3A , left or right), which suggests a complete p-orbital connectivity for each dipyrrinone group and provides the putative structural mechanism underlying the 48 nm red shift in absorption upon bilirubin binding. BR forms many hydrogen bonds with UnaG via well-ordered water molecules ( Figure 3C ). These interactions may be compared to other FABP-ligand complexes ( Figures 3D and  S3A ). In human B-FABP, for example, the bound fatty acid docosahexaenoic acid (DHA) forms hydrogen bonds via its carboxylate with Arg127 and Tyr129 residues (Balendiran et al., 2000) . This hydrogen bonding is highly conserved in many FABP-ligand interactions and may play a critical role in ligand binding (Storch and Thumser, 2000; Schaap et al., 2002; Zimmerman and Veerkamp, 2002) . Similar hydrogen bonds are seen in holoUnaG that involve the B-ring propionate carboxylate and Arg132/Tyr134 residues ( Figure S3A ). However, the exovinyl dipyrrinone moiety is buried deeper in the b barrel than the carboxylate, and the whole BR molecule is attached to the protein by many other hydrogen bonds. This tight coordination of BR is a unique feature of holoUnaG compared to other FABP holoprotein complexes and explains the high affinity and specificity of BR binding in contrast with the lower affinities and broader binding spectra of other FABP ligands.
Asn57 resides near the cavity entrance and interacts with the endo-vinyl dipyrrinone moiety as well as C-ring propionate, and its mutation generated variants that absorbed light maximally around 500 nm but produced less (N57Q) or no (N57A) fluorescence emission ( Figure S3B ). We determined crystal structures of these mutant holoproteins to confirm the disrupted structural mechanism ( Figure S3C ). High-Affinity and -Specificity Binding of UnaG to Unconjugated Bilirubin In medicine, the biosynthetic form of BR (4Z, 15Z-bilirubin IXa) is called unconjugated BR (UC-BR). UC-BR is a lipophilic molecule transported in blood plasma mostly via serum albumin to the liver, where it is converted to BR glucuronide, also called conjugated BR (C-BR) and excreted into the bile (Figure S4) . We used apoUnaG to examine the affinity and specificity of its binding to UC-BR and determined a K d value of 98 pM ( Figure 4A ). Of note, no other BR-related compounds (Figure S4 )-ditauroBR (alternative C-BR), biliverdin (BV), or urobilin-rendered apoUnaG fluorescent ( Figure 4B ). These results demonstrate the high-affinity and -specificity binding of apoUnaG to UC-BR, consistent with the compact ligand-protein complex revealed by the structure.
Clinical Application of ApoUnaG for Quantification of Human Bilirubin
We examined whether UnaG could be used as a fluorescent sensor for the clinical measurement of UC-BR, a metabolite that is commonly associated with important health implications such as proper liver function. UC-BR is normally present in human blood at low concentrations, but when hemoglobin breakdown is increased or glucuronic acid conjugation is impaired, UC-BR accumulates in the circulation system and extravascular tissue and may cause the pervasive childhood diseases of jaundice and kernicterus (Wennberg et al., 2006 ). An efficient diagnostic method is required that can directly measure serum levels of UC-BR, but current methods for UC-BR measurement using light absorption are insensitive, indirect, and have not changed since 1916 (Lo and Doumas, 2011) . Therefore, we reasoned that UnaG could be an ideal reagent for the design of a new bilirubin candidate clinical test using high-resolution fluorescence.
UC-BR exists as either a free or protein-bound form in human serum (Table S3 ). As shown in Figure S2C , a large amount of UC-BR was detected in fractions containing human serum albumin (HSA) and only a small amount in HDL fractions. Thus, we focused on HSA as the principal UC-BR-binding protein.
Although the crystal structure of the HSA/UC-BR complex was determined (Zunszain et al., 2008) , the binding properties are not well understood. Also, though fluorescence of HSA/UC-BR complex has been studied (Zucker et al., 1995; Athar et al., 1999) , it is negligibly dark compared with that of holoUnaG (Figures 5A and 5B). The affinity reported for UC-BR binding to HSA varies greatly (Petersen et al., 2000; Weisiger et al., 2001) ; most K d values fall in a range of 10 À8 -10 À6 M. We measured absorption spectra to titrate UC-BR with recombinant HSA (rHSA) and determined the K d to be 87 nM ( Figure S5 ). Due to about three orders of magnitude difference in affinity (98 pM versus 87 nM), nearly all UC-BR molecules will be bound to apoUnaG rather than (r)HSA in an equilibrium state in which the two proteins exist with similar concentrations ( Figure 5C ). Considering the signal linearity that covers UC-BR concentrations in hyperbilirubinemia ($25 mg/dl), we constructed a fluorometric method with 2 mM apoUnaG in phosphate-buffered saline (PBS). With a 200-fold dilution of a serum sample with this solution, it is possible to accurately quantify serum levels of all forms of UC-BR in 10 min ( Figure 6A ). This highly sensitive method requires only a small amount of serum, is free from complicated mathematical corrections, and is indifferent to interference, such as hemolysis. To demonstrate the proof of principle, we performed large-scale measurements comparing human serum samples spiked with UC-BR ( Figure 6B ) and volunteer blood samples (Figures S6A and S6B) and were able to demonstrate the applicability of our fluorescent method while emphasizing the limitations of conventional methodology. Due to the simplicity, we propose that this method will be helpful to clinical labs worldwide who run blood panels including bilirubin, and, in particular, pediatricians and pediatric caregivers who treat low birth weight infants in whom high levels of UC-BR may cause jaundice and kernicterus.
UnaG Expression in Eel Is Restricted to Small-Diameter Muscle Fibers
The FABP family has been implicated in metabolism, including oxidative stress homeostasis. Likewise, bilirubin has been proposed to serve as an antioxidant in metabolic stress. Together, these observations suggest that UnaG is a candidate regulatory molecule in eel skeletal muscle metabolic physiology. However, the biological function of UnaG binding to bilirubin and the generation of fluorescence in juvenile eel muscle remain unclear. As the only practical entry point to this question at present, we studied the native tissue-specific expression pattern of UnaG in eel muscle. In eels, postlarval muscle growth occurs primarily in white muscle fibers. In transverse sections, we observed a typical mosaic appearance in which fibers of different sizes intermingled. This type of mosaic muscle hyperplasia is a particular feature of fish that reach large final sizes (Rowlerson et al., 1985) . In juvenile Japanese eels of less than 10 cm long, we observed green fluorescence (UnaG FL) deep in the white muscle layer ( Figure 7A ), but not in gill, heart, liver, or digestive organs ( Figure 7B ). Strikingly, within the mosaic pattern, UnaG fluorescence was specifically restricted to small-diameter muscle fibers that are generally believed to represent the most recently developed fibers during muscle growth. Notably, although smalldiameter fibers were scattered throughout the white muscle layer, only those localized deep around the radial core of the eel's axis were fluorescent ( Figure 7C ). To determine whether the central axial pattern of fluorescence distribution reflected protein expression of apoUnaG or its reconstitution with bilirubin, we prepared an antibody (TF0231) and immunolocalized UnaG protein ( Figure 7D ). Red UnaG protein immunofluorescence matched the UnaG green fluorescence, indicating that UnaG exists as a holoprotein in eel muscle and that synthesis and transport of bilirubin are efficient in the eel body. Furthermore, an in situ hybridization experiment confirmed that UnaG mRNA was localized exclusively in small-diameter fibers (Figure 7E) , which suggests that gene expression of UnaG attenuates as muscles initially grow, further implicating a potential functional role of UnaG in juvenile eel muscle metabolism.
DISCUSSION
The observation of fluorescence in muscle of the Japanese eel has led to the discovery and characterization of UnaG, a novel green fluorescent protein with a fundamentally different biological source and fluorescence mechanism compared to other known fluorescent proteins. UnaG is the first known fluorescent protein from the vertebrate subphylum, which may endow it with superior experimental advantages and medical applications compared to proteins from lower organisms. UnaG is also the first protein whose fluorescence must be activated by a natural ligand, which we identified as unconjugated bilirubin, a lipophilic heme metabolite, raising the possibility of designing genetically encoded inducible fluorescent protein switches for a variety of research applications. Moreover, the oxygen-independent feature of UnaG will allow it to be used as the green spectral channel in anaerobic conditions in which EGFP is inactive. The atomic structure of UnaG revealed a molecular mechanism of fluorescence based on reversible p conjugation. We also show that UnaG has direct translational application as a superior quantitative diagnostic assay that may supplant the current global clinical standard. Finally, UnaG is efficiently expressed in mammalian systems in vivo and will serve as a template for the targeted development of a versatile new class of inducible fluorescent proteins.
Comparison of UnaG to Current Fluorescent Proteins
The discovery and utilization of fluorescent proteins in biological research has allowed rapid advances in many fields of biomedical research in recent years. Aequorea GFPs and GFP-like proteins, the most commonly used sensors in research, autocatalytically create their chromophores from amino acid side chains (Tsien, 1998; Miyawaki et al., 2012) . However, the utility of these fluorescent proteins is limited by the requirement of molecular oxygen for chromophore formation/maturation. Flavin mononucleotide (FMN)-based fluorescent proteins (FbFPs) have also recently been developed by engineering the blue-light-sensitive light oxygen voltage domains (LOVs) of bacterial photoreceptors (Drepper et al., 2007) . However, because FMN is ubiquitous in life, FbFP shows constitutive emission. Although FbFPs can be used as fluorescent reporters in aerobic and anaerobic biological systems, unfortunately their fluorescence is weak. It is important to have fluorescent reporters that reliably produce signals regardless of oxygen limitations because hypoxic or anoxic conditions are commonly seen in biomedical research conditions that involve cancer, ischemia, parasite infection, and low cellular metabolic states. Also, optical study of microbial and other organisms that live in anaerobic environments like the intestine has been constrained by the lack of available oxygen-independent green sensors.
Near-infrared (NIR) fluorescent proteins, such as IFP1.4 (Shu et al., 2009) , iRFP (Filonov et al., 2011) , and Wi-Phy (Auldridge et al., 2012) , have recently been developed from bacteriophytochromes, and these proteins require biliverdin for chromophore development. Phytochromes-photoreceptors found in fungi, plants, bacteria, and cyanobacteria-carry bilins (linear tetrapyrrole compounds) as their chromophores (phytochromobilins) (Rockwell et al., 2006) . Also, phycobiliproteins, lightcapturing proteins found in cyanobacteria and certain algae, utilize phycobilins as their fluorogenic chromophores (Glazer, 1989) . However, because no bilin-binding proteins found in the plant/protozoan kingdom carry unconjugated bilirubin as a chromophore and show noncovalent binding to the ligand A) Our method for measurement of unconjugated bilirubin (UC-BR) consists of a 200 ml reaction mixture containing 2 mM apoUnaG (0.4 nmol) and 1 ml serum sample (200-fold dilution) in PBS. After mixing, fluorescence intensities from multiple samples were measured using a plate reader every 10 min. The intensities reached their maximum levels in 10-20 min and were stable for >1 hr. The signal stability should enable reproducible measurement of UC-BR. It is noted that the azopigment formation or oxidation in the conventional methods occurs gradually, and the reaction rate varies among BR species. (B) Comparison of the fluorescent readouts of our method with the absorptive readouts of a conventional method using bilirubin oxidase. Measured fluorescence intensities were plotted as a function of the concentration of added UC-BR to make a standard curve (red). Additionally, measured fluorescence intensities of the human serum spiked with UC-BR were plotted against the concentration of indirect BR, which was determined based on the oxidation method by an outsourcing service (black). The two linear relationships (regression equations) are very similar. Data represent the means of three measurements. See also Figure S6 . and holoUnaG (green), which contained 10 mM UC-BR; 10 mM UC-BR and 10 mM rHSA; and 10 mM UC-BR and 10 mM apoUnaG, respectively. Values on the y axis are molar extinction coefficients. See also Figure S5. (B) Emission spectra of holoUnaG (green), UC-BR (yellow), and rHSA complexed with UC-BR (black). (Inset) The same spectral graph with the y axis expanded 1,000 times. Although UC-BR fluorescence intensity is enhanced when bound to serum albumin, the enhancement is negligible compared to the fluorescence of holoUnaG. (C) We explored the possibility that all of the UC-BR molecules are bound to added apoUnaG (2 mM) in a serum sample. Even with its moderate affinity for UC-BR, the presence of HSA in the serum sample at a high concentration (3.4-5.4 g/dl; 0.51-0.81 mM) may trap a significant fraction of UC-BR molecules. As hypoalbuminemia usually occurs, whereas hyperalbuminemia is rare, the concentration of HSA is assumed to be no more than 1 mM. Supposing that a serum sample contained 1 mM HSA and an average concentration of UC-BR (10 mM), we examined the appropriate dilution of the serum sample for the effective detection of UC-BR by 2 mM apoUnaG. A 200-fold dilution would result in 5 mM HSA and 50 nM UC-BR; the 5 mM HSA and the 2 mM apoUnaG would compete for the 50 nM UC-BR in the reaction mixture. Taking the Kd values of HSA/UC-BR and apoUnaG/UC-BR into account, we estimated that nearly all of the UC-BR molecules would be incorporated to generate holoUnaG. To verify this estimation, we performed a simple simulation experiment. We compared the maximal level of UnaG fluorescence in the absence and presence of 5 mM rHSA. The fluorescence intensities reached the same level in 10 min, irrespective of the preformation of rHSA/UC-BR complexes. These results indicated that 2 mM apoUnaG was able to quantify the total amount of UC-BR molecules even in the presence of (r)HSA and that a 200-fold or greater dilution of serum samples would be suitable for the purpose. chromophore, UnaG can be regarded as an entirely novel bilinbinding protein.
UnaG also has distinct differences from known FABP family members. The coordination by FABP of a heme molecule and not the expected fatty acid represents a remarkable convergent adaptation of evolution within the FABP family occurring after the vertebrate radiation, suggesting that UnaG has a role in advanced metabolism. Bilirubin binding to UnaG is positioned deep within the barrel structure in contrast to other FABP family members, which have shallow binding ligand pockets with broad spectra (Figures 3D and S3A) . Therefore, the high-affinity and high-specificity binding to bilirubin also make UnaG unique within the FABP family.
In mouse embryonic brain ( Figure 1C ) or cultured mammalian cells ( Figures 1D and 1E) , in which UC-BR is amply produced or supplemented, UnaG expression yields bright fluorescence in an oxygen-independent manner. On bacterial transformation with UnaG cDNA, there is no fluorescence (Figure S1 ), but subsequent application of exogenous bilirubin renders the transformed bacteria fluorescent ( Figure S1D ). Therefore, in cell types that produce no endogenous bilirubin, UnaG may be used as a switch-like fluorogenic probe. Alternately, UnaG may be genetically engineered to bind a bilirubin chemical variant that is not found in eukaryotic cells, permitting a unique inducible chemical-genetic fluorescent optical system. Other fluorogenic probes have been developed that employ covalent conjugation of ligands to protein tags (Sadhu et al., 2011) . In most cases, the ligands are synthetic chemicals containing both chromophores and quenchers. They remain nonfluorescent due to intramolecular association-induced quenching until they become covalently attached to their respective tags for spatial separation of the chromophores from the quenchers. In contrast, bilirubin is a natural chromogenic compound, which is fully accommodated in the protein barrel of UnaG. Altogether, UnaG will expand the conventional conception about ligandprotein interactions of fluorescent proteins and may also extend their research utility to inducible applications such as optical pulse-chase experiments.
Development of a Fluorescence-Based Clinical Assay for Bilirubin
In most clinical laboratories, bilirubin measurement is a common test for liver function, and determining UC-BR levels in newborns with jaundice is considered a standard medical practice. At present, UC-BR levels in plasma/serum are quantified by a convoluted and imprecise method involving absorptiometry of native or derivatized tetrapyrroles. For example, during the conversion to azoderivatives, C-BR reacts quickly with diazo reagents (''direct'' fraction), whereas UC-BR does so slowly (''indirect fraction''). Then total bilirubin (T-BR) is determined after adding an accelerator of the chemical conversion reaction, and UC-BR is calculated by subtracting C-BR from T-BR.
Identification of the UnaG ligand as UC-BR allowed us to develop a direct fluorometric assay with potential clinical application that is vastly superior in sensitivity, speed, reproducibility, economy, and simplicity to currently used absorptiometric methods. In addition, we demonstrated that apoUnaG is tolerant to lyophilization (Figure S6C ), so transportation and storage of the assay reagent requires neither cooling nor freezing. Clinical laboratories in remote rural areas can determine UC-BR levels without effort; the procedure simply consists of reconstitution of lyophilized apoUnaG with 200 ml PBS, addition of 1 ml sample, and measurement of the fluorescence after a 10 min incubation ( Figure S6C) .
It has been shown that low-nanomolar concentrations of UC-BR can protect cells from oxidative stress (Sedlak and Snyder, 2004) . Thus, future studies will include the development of UnaG mutants with different (lower) affinities for UC-BR through structure-guided mutagenesis and the creation of experimental animals transgenically expressing UnaG mutants. Using these approaches with UnaG, intravital imaging will allow unprecedented information about UC-BR biodistribution in tissue. Notably, the assay using apoUnaG is not affected by hemolysis, i.e., the presence of hemoglobin or red blood cells, and we verified measurement of UC-BR levels in blood samples (see Extended Experimental Procedures). This property raises the prospect that levels of circulating UC-BR in the human body may be monitored using an apoUnaG-containing device at the tip of a catheter. A variety of clinical evidence has accumulated that moderately elevated serum UC-BR levels are associated with a reduced risk of disease involving oxidative stress, such as cardiovascular disease (Sedlak and Snyder, 2004) and diabetes mellitus (Fukui et al., 2008) . Thus, the UnaG method using various human samples will enhance the value of UC-BR as a biomarker and may transform the ability of clinicians to monitor health status in daily life. We feel that UnaG may yield insight into the mechanistic functions of bilirubin in the body and may thus have medical implications for understanding heme metabolism in the healthy and disease states.
Implications of UnaG for Metabolism in Eel Muscle
Because larvae were first collected in the Philippine Sea, revealing their long-range migration pattern from Japan (Tsukamoto, 1992) , the catadromous life cycle of the Japanese freshwater eel has attracted significant public interest (Inoue et al., 2010 ). In the current study, we show that the UnaG-bilirubin fluorescent complex may serve as a new tool for experimental biology. However, the findings may also provide an unexpected entry point to understanding eel muscle physiology that, in turn, could lead to more general biological insights into heme and oxidative stress metabolism, a relatively unexplored area of biology due to the lack of specific molecular sensors and tools, which UnaG may now provide.
Bilirubin is known to function as a powerful physiological antioxidant and cytoprotectant in vivo (Stocker et al., 1987; Kapitulnik, 2004; Maines, 2005) . In the oxidation-reduction cycle, biliverdin (BV) generated by bilirubin oxidation is efficiently reconverted to bilirubin by BV reductase, suggesting that low levels of bilirubin may be cytoprotective (Sedlak and Snyder, 2004) . The noncovalent binding of bilirubin to UnaG suggests that this interaction may regulate the dynamic transport or storage of free or transient pools of this metabolite, reducing cellular oxidative stress by preserving a pool of antioxidant molecules, which may contribute to the ability of freshwater eels to maintain oxidative muscle metabolism during longdistance migration in both the ocean and rivers. Moreover, it is interesting to consider the disposition of bound bilirubin in holoUnaG: whereas light and oxygen eventually degrade bilirubin molecules into colorless fragments, we found that bilirubin degradation was significantly slowed by binding to UnaG ( Figure S7A ).
These findings converge with reports of the proposed metabolic role of M-FABPs that are reported to be abundant in the flight muscles of migratory locusts and birds (Schaap et al., 2002; Qu et al., 2007) . In this model, the FABPs are proposed to act as both an intracellular buffer to protect cells from damage due to excess accumulation of detergent-like fatty acids and an intracellular fatty acid transporter to facilitate efficient fuel utilization during sustained effort. By these mechanisms, flight muscles may maintain high rates of fatty acid oxidation during long airborne journeys.
Though decisive examination of this antioxidant hypothesis in eel will require further cell-biological studies, we performed a preliminary examination on whether UnaG fluorescence is also observed in other species of eel that undergo long-distance migration. We found that two other long-distance migratory freshwater eels (Anguilla anguilla and Anguilla rostrata) also contain bright green fluorescence in their white muscle, whereas an oceanodromous sea eel (Conger myriaster) does not (Figure S7B) . These results require follow-up studies, but it is evident that UnaG can be used as a tool for the investigation of skeletal muscle physiology and metabolism during endurance exercise, with potential implications for biomedical science. We also believe that the discovery of UnaG will open avenues to study and conserve the biologically mysterious, economically significant, and ecologically threatened freshwater eel.
EXPERIMENTAL PROCEDURES Freshwater Eels
Glass eels (Anguilla japonica) were commercially obtained from a dealer (Kenis, Osaka) in Japan. Aqua-cultured and wild-caught eels (Anguilla japonica, Anguilla Anguilla, and Anguilla rostrata) and common Japanese conger (Conger myriaster) were obtained from local dealers or commercial fishermen.
cDNA Cloning and Gene Construction Total RNA was isolated from the glass eel samples by guanidine thiocyanate extraction. Synthesis and amplification of the fragment of interest using degenerate primers were performed as described previously (Karasawa et al., 2003) . The full-length cDNA was generated using 5 0 RACE System for rapid amplification of cDNA ends (Invitrogen) and was cloned into pT7BlueT vector for sequence analysis. The cDNA of the coding region was amplified using primers containing 5 0 -BamHI and 3 0 -EcoRI sites. The restricted product was cloned in frame into the BamHI/EcoRI sites of pRSETB (Invitrogen) and pGEX-2T (GE Healthcare) for bacterial expression of His-tagged UnaG and GST-tagged UnaG, respectively. Also, the BamHI/EcoRI fragment was subcloned into pcDNA3/FLAG for mammalian expression of FLAG-tagged UnaG. pcDNA3/FLAG was constructed by inserting a sequence coding the FLAG tag into the KpnI/BamHI sites of pcDNA3 (Invitrogen). Site-directed mutations were introduced using GENEART Site-Directed Mutagenesis System (Invitrogen). For synthesis of digoxigenin-labeled antisense and sense RNA probes, the UnaG cDNA was cloned in pBlueScript (Stratagene).
HoloUnaG Protein Expression in Cultured Mammalian Cells
HEK293T or HeLa cells were grown in DMEM supplemented with 10% FBS (GIBCO). Cells were transiently transfected with cDNA encoding FLAG-tagged UnaG using FuGene HD (Promega). After cell lysis, protein was bound to an anti-FLAG M2-agarose affinity gel (Sigma), eluted with FLAG peptide (Sigma), and concentrated using Amicon Ultra-15 (3,000 MW cut off) (Millipore); the protein solution was loaded on a PD-10 column (GE Healthcare) for exchange of buffer and elimination of the FLAG peptide.
Extraction of Ligand from HoloUnaG
Extraction was performed according to the method by Bligh and Dyer (1959) . Details are provided in Extended Experimental Procedures.
ApoUnaG Protein Expression in Bacteria
Proteins were expressed in Escherichia coli (BL21[DE3] or JM109[DE3]) and purified using Ni 2+ or glutathione-affinity chromatography as described previously (Ando et al., 2002) . In the latter case, UnaG protein was obtained from GST-UnaG protein adsorbed on glutathione Sepharose 4B (GE Healthcare) by thrombin (GE Healthcare) digestion. Thrombin was eliminated from the final sample using benzamidine Sepharose 6B (GE Healthcare). Because GST (glutathione S-transferase) is known to be a bilirubin-binding protein (ligandin) (Arias et al., 1980) , great care was taken to exclude it. Purity of the apoUnaG sample was checked by SDS/PAGE analysis.
Preparation of HoloUnaG from ApoUnaG and Bilirubin
Bilirubin (Wako) was dissolved in DMSO to prepare a stock solution (1 mM), which was diluted with PBS. For preparation of holoUnaG, apoUnaG and bilirubin were mixed with 1:2 stoichiometry in PBS containing certain concentrations of DMSO. Formation of holoUnaG was checked by fluorescence development. The holoUnaG sample was applied to a PD-10 column for elimination of DMSO and free bilirubin. As necessary, the protein sample was concentrated using Amicon Ultra (3,000 MW cutoff).
Imaging of HoloUnaG in HeLa Cells, In Vitro Spectroscopy, and Histology Technical details are described in Extended Experimental Procedures.
Crystallization, X-Ray Data Collection, Structure Determination, and Refinement Technical details are described in Extended Experimental Procedures, and data collection and refinement statistics are summarized in Table S2 .
Measurement of Serum Levels of UC-BR
The procedure was extremely simple. PBS containing 2 mM apoUnaG was used as the reaction solution. All measurements were done in triplicate. In brief, 3 ml of serum was mixed with 597 ml of the reaction solution for both 200-fold dilution and reaction initiation. The reaction mixture was left standing for at least 10 min, when reproducible results can be obtained regardless of any additional incubation time due to the stability of the developed fluorescence ( Figure 6A ). Fluorescence emissions from mixture aliquots (200 ml each) were measured in a 96-well microplate (Model #955900, Greiner Bioone) using the EnSpire Multimode Plate Reader (Perkin Elmer) with 497 nm excitation and 527 nm emission. A PBS containing no apoUnaG was for calibration. Because serum samples of hyperbilirubinemia were not available, human serum (Kohjin Bio) samples spiked with various amounts of BR were used. The same serum samples were analyzed by an outsourcing service (Mitsubishi Chemical Medience), which employs the oxidation method to measure direct BR ( = C -BR) and total BR for the calculation of indirect BR ( = UC -BR). Although conventional absorptiometric methods are much less sensitive and should accordingly be intolerant of such a significant degree of sample dilution, our fluorometric method is sensitive enough to allow a 200-fold or more dilution. Because the diluted serum sample shows a very low absorbance (<0.002) at the wavelength for UnaG excitation (497 nm), the inner filter effect can be ignored. A recent study developed a fluorometric method for quantifying free UC-BR by using a mutated FABP conjugated with acrylodan or rhodamine B (Huber et al., 2012) . Although the mutated FABP binds to UC-BR with a K d value of 16 nM, the method is relatively complicated with corrections and mathematical models. By contrast, our method takes advantage of the ultrahigh affinity (K d = 98 pM) of apoUnaG and simply assumes that the UC-BR/apoUnaG complex predominates in a reaction mixture. The study using volunteer serum samples was approved by the Ethical Committee of the RIKEN Safety Division. Written informed consent was obtained from the volunteers.
ACCESSION NUMBERS
The sequence for UnaG has been deposited in the DDBJ/EMBL/GenBank databases (accession number AB763906). Atomic coordinates and structure factors for the reported crystal structures have been deposited with the Protein Data Bank under accession codes 4I3B (wild-type UnaG), 4I3C (N57Q), and 4I3D (N57A). 
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